This episode focuses on the work of scientist Ali Ellebedy, PhD, who has published several papers about the immune response to vaccines and COVID-19 infection.
(July 15, 2021) WashU Med researchers have received $8 million from the NIH for projects studying whether frequent COVID-19 testing can reduce the spread of the virus.
(July 15, 2021) A WashU Med study finds that the immune response to the first two COVID-19 vaccines approved for emergency use is both strong and potentially long-lasting.
The study helps explain why coronavirus infection has been linked to serious pregnancy complications, such as preeclampsia, that threaten the health of both mother and fetus.
Sean Whelan and Michael Diamond teamed up early in the pandamic to ramp up COVID-19 research while the rest of the world was shutting down.
A WashU Med study shows that even mild cases of COVID-19 increase the risk of death in the six months following diagnosis. Risk increases with disease severity.
The study aims to determine who is more likely to develop a breakthrough case.
Vaccinated, nursing moms may pass protective antibodies to their babies for at least 80 days , suggests new research from WashU Med.
Alfred Kim has initiated a clinical trial to evaluate the antibody response in patients taking immunosuppressant drugs. He is recruiting WashU Med health-care workers and patients.
A clinical trial of the Johnson & Johnson/Janssen COVID-19 vaccine, in which WashU Med participated, found the vaccine’s effectiveness to be comparable to the Pfizer-BioNTech and Moderna vaccines.